{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:22:18Z","timestamp":1790680938086,"version":"4.1.0"},"reference-count":52,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Cycle"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.4161\/cc.24805","type":"journal-article","created":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T04:08:42Z","timestamp":1370059722000},"page":"1722-1731","source":"Crossref","is-referenced-by-count":27,"title":["Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner"],"prefix":"10.1080","volume":"12","author":[{"given":"Sue","family":"Haupt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Corneille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Shortt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Castillo-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Bonal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cordon-Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ygal","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,11,3]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"a001107","DOI":"10.1101\/cshperspect.a001107","article-title":"Mutant p53 gain-of-function in cancer","volume":"2","author":"Oren","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"Olive","year":"2004","journal-title":"Cell"},{"key":"R3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","article-title":"Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome","volume":"119","author":"Lang","year":"2004","journal-title":"Cell"},{"key":"R4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrc2731","article-title":"20 years studying p53 functions in genetically engineered mice","volume":"9","author":"Donehower","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R5","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1101\/gad.1662908","article-title":"The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss","volume":"22","author":"Terzian","year":"2008","journal-title":"Genes Dev"},{"key":"R6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"R7","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1128\/MCB.00050-07","article-title":"Ubiquitination and degradation of mutant p53","volume":"27","author":"Lukashchuk","year":"2007","journal-title":"Mol Cell Biol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"33134","DOI":"10.1074\/jbc.M301264200","article-title":"The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation","volume":"278","author":"Louria-Hayon","year":"2003","journal-title":"J Biol Chem"},{"key":"R9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb1147","article-title":"PML regulates p53 stability by sequestering Mdm2 to the nucleolus","volume":"6","author":"Bernardi","year":"2004","journal-title":"Nat Cell Biol"},{"key":"R10","doi-asserted-by":"crossref","first-page":"49286","DOI":"10.1074\/jbc.M308302200","article-title":"MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53","volume":"278","author":"Zhu","year":"2003","journal-title":"J Biol Chem"},{"key":"R11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(91)90113-D","article-title":"The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR","volume":"66","author":"de Th\u00e9","year":"1991","journal-title":"Cell"},{"key":"R12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.193.4.521","article-title":"Role of promyelocytic leukemia (PML) protein in tumor suppression","volume":"193","author":"Rego","year":"2001","journal-title":"J Exp Med"},{"key":"R13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/35036365","article-title":"The function of PML in p53-dependent apoptosis","volume":"2","author":"Guo","year":"2000","journal-title":"Nat Cell Biol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0962-8924(01)01983-3","article-title":"P53 and PML: new partners in tumor suppression","volume":"11","author":"Gottifredi","year":"2001","journal-title":"Trends Cell Biol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4161\/cc.5.22.3504","article-title":"A cytoplasmic PML mutant inhibits p53 function","volume":"5","author":"Bellodi","year":"2006","journal-title":"Cell Cycle"},{"key":"R16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jnci\/djh043","article-title":"Loss of the tumor suppressor PML in human cancers of multiple histologic origins","volume":"96","author":"Gurrieri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature04809","article-title":"Identification of a tumour suppressor network opposing nuclear Akt function","volume":"441","author":"Trotman","year":"2006","journal-title":"Nature"},{"key":"R18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cell.2006.05.041","article-title":"A CK2-dependent mechanism for degradation of the PML tumor suppressor","volume":"126","author":"Scaglioni","year":"2006","journal-title":"Cell"},{"key":"R19","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.279.5356.1547","article-title":"Role of PML in cell growth and the retinoic acid pathway","volume":"279","author":"Wang","year":"1998","journal-title":"Science"},{"key":"R20","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1158\/0008-5472.CAN-08-4010","article-title":"Promyelocytic leukemia protein is required for gain of function by mutant p53","volume":"69","author":"Haupt","year":"2009","journal-title":"Cancer Res"},{"key":"R21","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1093\/emboj\/19.22.6185","article-title":"Regulation of p53 activity in nuclear bodies by a specific PML isoform","volume":"19","author":"Fogal","year":"2000","journal-title":"EMBO J"},{"key":"R22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/cdd.2011.103","article-title":"The circadian mutation PER2(S662G) is linked to cell cycle progression and tumorigenesis","volume":"19","author":"Gu","year":"2012","journal-title":"Cell Death Differ"},{"key":"R23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0695-175","article-title":"A subset of p53-deficient embryos exhibit exencephaly","volume":"10","author":"Sah","year":"1995","journal-title":"Nat Genet"},{"key":"R24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0960-9822(95)00183-7","article-title":"High-frequency developmental abnormalities in p53-deficient mice","volume":"5","author":"Armstrong","year":"1995","journal-title":"Curr Biol"},{"key":"R25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/dneu.20581","article-title":"Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes","volume":"68","author":"Chen","year":"2008","journal-title":"Dev Neurobiol"},{"key":"R26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMc1012718","article-title":"p53 lesions in leukemic transformation","volume":"364","author":"Harutyunyan","year":"2011","journal-title":"N Engl J Med"},{"key":"R27","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1038\/sj.onc.1206541","article-title":"The onset of p53-dependent apoptosis plays a role in terminal differentiation of human normoblasts","volume":"22","author":"Peller","year":"2003","journal-title":"Oncogene"},{"key":"R28","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/annonc\/mdl445","article-title":"Clinical signs and symptoms at diagnosis and its differential diagnosis","volume":"18","author":"Mellstedt","year":"2007","journal-title":"Ann Oncol"},{"key":"R29","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press. Lyon: IARC Press, 2008."},{"key":"R30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mc.2940140105","article-title":"Effects of genetic background on tumorigenesis in p53-deficient mice","volume":"14","author":"Donehower","year":"1995","journal-title":"Mol Carcinog"},{"key":"R31","doi-asserted-by":"crossref","first-page":"a000893","DOI":"10.1101\/cshperspect.a000893","article-title":"p53 Research: the past thirty years and the next thirty years","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"key":"R33","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.4161\/cc.10.19.17721","article-title":"The ups and downs of p53 regulation in hematopoietic stem cells","volume":"10","author":"Abbas","year":"2011","journal-title":"Cell Cycle"},{"key":"R34","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2006-03-010413","article-title":"The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging","volume":"109","author":"Dumble","year":"2007","journal-title":"Blood"},{"key":"R35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0301-472X(03)00072-9","article-title":"Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice","volume":"31","author":"TeKippe","year":"2003","journal-title":"Exp Hematol"},{"key":"R36","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"key":"R37","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.4161\/cc.8.17.9462","article-title":"PML: a tumor suppressor that regulates cell fate in mammary gland","volume":"8","author":"Li","year":"2009","journal-title":"Cell Cycle"},{"key":"R38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jcp.22161","article-title":"PML down-regulation in soft tissue sarcomas","volume":"224","author":"Vincenzi","year":"2010","journal-title":"J Cell Physiol"},{"key":"R39","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jcp.22889","article-title":"PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents\/antracycline-based first line therapy","volume":"227","author":"Vincenzi","year":"2012","journal-title":"J Cell Physiol"},{"key":"R40","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/cncr.22680","article-title":"High prevalence of p53 exon 4 mutations in soft tissue sarcoma","volume":"109","author":"Das","year":"2007","journal-title":"Cancer"},{"key":"R41","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/emboj.2012.1","article-title":"PML regulates PER2 nuclear localization and circadian function","volume":"31","author":"Miki","year":"2012","journal-title":"EMBO J"},{"key":"R42","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1038\/onc.2008.305","article-title":"Regulation of apoptosis by PML and the PML-NBs","volume":"27","author":"Bernardi","year":"2008","journal-title":"Oncogene"},{"key":"R43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","article-title":"The RB and p53 pathways in cancer","volume":"2","author":"Sherr","year":"2002","journal-title":"Cancer Cell"},{"key":"R44","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1128\/MCB.18.7.3735","article-title":"Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain","volume":"18","author":"Frazier","year":"1998","journal-title":"Mol Cell Biol"},{"key":"R45","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1038\/sj.onc.1210128","article-title":"PML4 induces differentiation by Myc destabilization","volume":"26","author":"Buschbeck","year":"2007","journal-title":"Oncogene"},{"key":"R46","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1038\/onc.2011.441","article-title":"Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma","volume":"31","author":"Torchia","year":"2012","journal-title":"Oncogene"},{"key":"R47","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev"},{"key":"R48","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1038\/sj.onc.1211036","article-title":"PML enhances the regulation of p53 by CK1 in response to DNA damage","volume":"27","author":"Alsheich-Bartok","year":"2008","journal-title":"Oncogene"},{"key":"R49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11912-012-0223-2","article-title":"Targeted therapy in bone and soft tissue sarcoma in children and adolescents","volume":"14","author":"Thompson","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"R50","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02940312","article-title":"Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas","volume":"13","author":"Chang","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"R51","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.4161\/cc.22043","article-title":"Restoring PML tumor suppression to combat cancer","volume":"11","author":"Wolyniec","year":"2012","journal-title":"Cell Cycle"},{"key":"R52","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/cdd.2009.31","article-title":"E6AP promotes the degradation of the PML tumor suppressor","volume":"16","author":"Louria-Hayon","year":"2009","journal-title":"Cell Death Differ"}],"container-title":["Cell Cycle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/cc.24805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T13:59:49Z","timestamp":1498053589000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/cc.24805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,3]]},"published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.4161\/cc.24805"],"URL":"https:\/\/doi.org\/10.4161\/cc.24805","relation":{},"ISSN":["1538-4101","1551-4005"],"issn-type":[{"value":"1538-4101","type":"print"},{"value":"1551-4005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}